Skip to main content
Year archive

CSPC Pharmaceutical Group Limited — 2019 filings

All 80 regulatory filings released by CSPC Pharmaceutical Group Limited (1093) in 2019, sourced directly from the official regulator.

80 Filings
2019 Period
2019 filings (80)
Filing Released Lang
VOLUNTARY ANNOUNCEMENT - TERMINATION OF PRODUCT CO-DEVELOPMENT AND STRATEGIC COLLABORATION AGREEMENT
Regulatory Filings
2019-12-30 English
VOLUNTARY ANNOUNCEMENT - THE GROUP'S "PREGABALIN CAPSULES" WAS GRANTED THE U.S. ANDA APPROVAL
Regulatory Filings
2019-12-30 English
VOLUNTARY ANNOUNCEMENT - NEW DRUG APPROVAL OF THE GROUP'S "LEVOAMLODIPINE MALEATE TABLETS" GRANTED BY THE U.S. FDA
Regulatory Filings
2019-12-20 English
VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR THE GROUP'S "IBUPROFEN TABLETS"
Regulatory Filings
2019-12-11 English
REVISION OF ANNUAL CAPS FOR EXISTING CONTINUING CONNECTED TRANSACTIONS
Regulatory Filings
2019-12-09 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2019
Major Shareholding Notification
2019-12-02 English
VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR THE GROUP'S "CEFIXIME CAPSULES"
Regulatory Filings
2019-11-27 English
VOLUNTARY ANNOUNCEMENT - SUBMISSION OF CLINICAL TRIAL APPLICATION FOR INVESTIGATIONAL FIRST-IN-CLASS NEW DRUG ALMB-0168 IN AUSTRALIA
Regulatory Filings
2019-11-27 English
QUARTERLY RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2019
Interim / Quarterly Report
2019-11-18 English
VOLUNTARY ANNOUNCEMENT - PRODUCT TRANSFER AGREEMENT
Capital/Financing Update
2019-11-07 English
DATE OF BOARD MEETING
Regulatory Filings
2019-11-06 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2019
Major Shareholding Notification
2019-11-01 English
VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR THE GROUP'S "CEPHALEXIN CAPSULES"
Regulatory Filings
2019-11-01 English
VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR THE GROUP'S "CLINDAMYCIN HYDROCHLORIDE CAPSULES"
Regulatory Filings
2019-11-01 English
VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR THE GROUP'S "ENALAPRIL MALEATE TABLETS"
Regulatory Filings
2019-11-01 English
VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR THE GROUP'S "IBUPROFEN GRANULES"
Regulatory Filings
2019-10-31 English
VOLUNTARY ANNOUNCEMENT - "RECOMBINANT ANTI-EpCAM AND ANTI-CD3 HUMAN-MOUSE CHIMERIC BISPECIFIC ANTIBODY FOR INJECTION" WAS GRANTED CLINICAL TRIAL APPROVAL BY U.S. FDA
Regulatory Filings
2019-10-31 English
VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF THE GROUP'S "DRONEDARONE HYDROCHLORIDE TABLET"
Regulatory Filings
2019-10-29 English
INSIDE INFORMATION - PRINCIPAL ACCOUNTING DATA AND FINANCIAL INDICATORS OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2019
Interim / Quarterly Report
2019-10-27 English
VOLUNTARY ANNOUNCEMENT - ANTI-TUMOR NANODRUG "EPIRUBICIN HYDROCHLORIDE LIPOSOME INJECTION" WAS GRANTED CLINICAL TRIAL APPROVAL
Regulatory Filings
2019-10-22 English
VOLUNTARY ANNOUNCEMENT - INVESTIGATIONAL NEW DRUG ALMB-0166 WAS GRANTED CLINICAL TRIAL APPROVAL IN AUSTRALIA
Regulatory Filings
2019-10-21 English
VOLUNTARY ANNOUNCEMENT - FIRST-IN-CLASS PRODUCT CANDIDATE ALMB-0168 GRANTED RARE PEDIATRIC DISEASE DESIGNATION BY THE U.S. FDA
Regulatory Filings
2019-10-18 English
INSIDE INFORMATION - ANNOUNCEMENT ON THE INDICATIVE RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2019 OF CSPC INNOVATION PHARMACEUTICAL CO., LTD .
Regulatory Filings
2019-10-14 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2019
Share Issue/Capital Change
2019-10-02 English
VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF THE GROUP'S "GLUTATHIONE FOR INJECTION"
Regulatory Filings
2019-09-26 English
VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF THE GROUP'S "METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS"
Regulatory Filings
2019-09-26 English
FIRST-IN-CLASS PRODUCT CANDIDATE ALMB-0168 WAS GRANTED ORPHAN-DRUG DESIGNATION BY THE U.S. FDA
Regulatory Filings
2019-09-23 English
NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED HOLDERS: NOTICE OF PUBLICATION OF 2019 INTERIM REPORT
Report Publication Announcement
2019-09-12 English
INTERIM REPORT 2019
Interim / Quarterly Report
2019-09-12 English
VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR THE GROUP'S "CEFUROXIME AXETIL TABLETS"
Regulatory Filings
2019-09-10 English
VOLUNTARY ANNOUNCEMENT - RECOMBINANT ANTI-HER2 AND ANTI-CD3 HUMANIZED BISPECIFIC ANTIBODY FOR INJECTION WAS GRANTED CLINICAL TRIAL APPROVAL BY U.S. FDA
Regulatory Filings
2019-09-02 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2019
Regulatory Filings
2019-09-02 English
VOLUNTARY ANNOUNCEMENT - NEW TARGET ANTI-TUMOR DRUG "SYHA1801" WAS GRANTED CLINICAL TRIAL APPROVAL
Regulatory Filings
2019-08-21 English
VOLUNTARY ANNOUNCEMENT - PRODUCT LICENSING AND COMMERCIALIZATION AGREEMENT
Regulatory Filings
2019-08-19 English
2019 INTERIM RESULTS ANNOUNCEMENT
Interim / Quarterly Report
2019-08-19 English
INSIDE INFORMATION - PRINCIPAL ACCOUNTING DATA AND FINANCIAL INDICATORS OF CSPC INNOVATION PHARMACEUTICAL CO., LTD.* FOR THE HALF YEAR ENDED 30 JUNE 2019
Interim / Quarterly Report
2019-08-18 English
VOLUNTARY ANNOUNCEMENT - SUBMISSION OF CLINICAL TRIAL APPLICATION FOR INVESTIGATIONAL FIRST-IN-CLASS NEW DRUG ALMB-0166 IN AUSTRALIA
Regulatory Filings
2019-08-15 English
DATE OF BOARD MEETING
Regulatory Filings
2019-08-07 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2019
Share Issue/Capital Change
2019-08-01 English
VOLUNTARY ANNOUNCEMENT - NEW TARGET ANTI-TUMOR DRUG "SYHA1807" WAS GRANTED CLINICAL TRIAL APPROVAL
Regulatory Filings
2019-07-29 English
INSIDE INFORMATION - ANNOUNCEMENT ON THE INDICATIVE RESULTS FOR THE HALF YEAR ENDED 30 JUNE 2019 OF CSPC INNOVATION PHARMACEUTICAL CO., LTD.*
Regulatory Filings
2019-07-12 English
CONTINUING CONNECTED TRANSACTIONS - RENEWAL OF STEAM SUPPLY AGREEMENT
Regulatory Filings
2019-07-12 English
CHANGE OF ADDRESS OF SHARE REGISTRAR AND TRANSFER OFFICE
Regulatory Filings
2019-07-02 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2019
Share Issue/Capital Change
2019-07-02 English
CORPORATE SOCIAL RESPONSIBILITY REPORT 2018
Environmental & Social Information
2019-06-28 English
CONNECTED TRANSACTIONS - LEASE AGREEMENTS
Regulatory Filings
2019-06-25 English
VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF THE GROUP'S "TICAGRELOR TABLETS"
Regulatory Filings
2019-06-13 English
VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF THE GROUP'S "CLOPIDOGREL BISULFATE TABLETS"
Regulatory Filings
2019-06-10 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2019
Share Issue/Capital Change
2019-06-03 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 27 MAY 2019
Declaration of Voting Results & Voting Rights Announcements
2019-05-27 English
CHANGE OF VICE-CHAIRMAN AND ROTATING CHIEF EXECUTIVE OFFICER
Board/Management Information
2019-05-21 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2019-05-21 English
QUARTERLY RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2019
Interim / Quarterly Report
2019-05-21 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2019
Share Issue/Capital Change
2019-05-20 English
DATE OF BOARD MEETING
Regulatory Filings
2019-05-08 English
VOLUNTARY ANNOUNCEMENT - FORMATION OF JOINT VENTURE
Capital/Financing Update
2019-05-07 English
INSIDE INFORMATION - PRINCIPAL ACCOUNTING DATA AND FINANCIAL INDICATORS OF CSPC INNOVATION PHARMACEUTICAL CO., LTD .* FOR THE THREE MONTHS ENDED 31 MARCH 2019
Interim / Quarterly Report
2019-04-28 English
VOLUNTARY ANNOUNCEMENT - NEW ORAL ANTI-COAGULANT DRUG "SYHA136" WAS GRANTED CLINICAL TRIAL APPROVAL
Regulatory Filings
2019-04-25 English
VOLUNTARY ANNOUNCEMENT - "PACLITAXEL CATIONIC LIPOSOME FOR INJECTION" FOR THE TREATMENT OF BREAST CANCER WAS GRANTED CLINICAL TRIAL APPROVAL
Regulatory Filings
2019-04-25 English
PROXY FORM FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON MONDAY, 27 MAY 2019 AT 10:00 A.M. (AND AT ANY ADJOURNMENT THEREOF)
Proxy Solicitation & Information Statement
2019-04-17 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2019-04-17 English
PROPOSALS FOR GENERAL MANDATES TO BUY-BACK SHARES AND TO ISSUE SHARES AND MANDATE TO GRANT OPTIONS, RE-ELECTION OF THE RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2019-04-17 English
ANNUAL REPORT 2018
Regulatory Filings
2019-04-17 English
VOLUNTARY ANNOUNCEMENT - "SYHA1803" FOR THE TREATMENT OF INTRAHEPATIC CHOLANGIOCARCINOMA AND UROTHELIAL CARCINOMA WAS GRANTED CLINICAL TRIAL APPROVAL
Regulatory Filings
2019-04-12 English
VOLUNTARY ANNOUNCEMENT - "SYHA1402" FOR THE TREATMENT OF DIABETIC NEUROPATHY WAS GRANTED CLINICAL TRIAL APPROVAL
Regulatory Filings
2019-04-12 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2019
Regulatory Filings
2019-04-02 English
UPDATES ON THE SPIN-OFF AND SEPARATE LISTING OF CSPC XNW GROUP ON THE CHINEXT OF SHENZHEN STOCK EXCHANGE
Capital/Financing Update
2019-03-20 English
ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2018
Annual Report
2019-03-18 English
DATE OF BOARD MEETING
Regulatory Filings
2019-03-06 English
VOLUNTARY ANNOUNCEMENT - SUBMISSION OF NDA TO U.S. FDA FOR LEVOAMLODIPINE MALEATE TABLETS
Regulatory Filings
2019-03-05 English
PROGRESS UPDATE ON THE PROPOSED SPIN-OFF AND SEPARATE LISTING OF CSPC XNW GROUP ON THE SHENZHEN STOCK EXCHANGE
Capital/Financing Update
2019-03-04 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2019
Regulatory Filings
2019-03-04 English
PROGRESS UPDATE ON THE PROPOSED SPIN-OFF AND SEPARATE LISTING OF CSPC XNW GROUP ON THE SHENZHEN STOCK EXCHANGE
Capital/Financing Update
2019-03-03 English
VOLUNTARY ANNOUNCEMENT - PRODUCT CO-DEVELOPMENT AND COMMERCIALIZATION AGREEMENTS
Capital/Financing Update
2019-02-26 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2019
Major Shareholding Notification
2019-02-04 English
GRANT OF SHARES PURSUANT TO THE SHARE AWARD SCHEME OF THE COMPANY
Share Issue/Capital Change
2019-01-15 English
UNUSUAL PRICE AND TRADING VOLUME MOVEMENT
Regulatory Filings
2019-01-10 English
VOLUNTARY ANNOUNCEMENT - ACQUISITION OF 100% INTEREST IN YONG SHUN TECHNOLOGY DEVELOPMENT LIMITED
Capital/Financing Update
2019-01-07 English
VOLUNTARY ANNOUNCEMENT - PRODUCT CO-DEVELOPMENT AND STRATEGIC COLLABORATION AGREEMENT
Regulatory Filings
2019-01-04 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2018
Share Issue/Capital Change
2019-01-02 English